Fem Care Pharma shoots up on getting merger nod

DALAL STREET SPIKES

The shares of Fem Care Pharma rose by 5.37 per cent to Rs 319.95 after the company's equity shareholders approved the scheme of amalgamation between Mirasu Marketing and Fem Care Pharma.

The approval is subject to the sanction of the Hon'ble High Court of Judicature at Mumbai. The stock has given negative returns of 20.82 per cent over the last one week and 6.67 per cent in a month. It registered a 52 week high of Rs 550 in June 2007 and 52 week low of Rs 287.9 on 14 February this year.